Departments of Biostatistics and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School Boston, MA, USA.
Biostatistics. 2020 Apr 1;21(2):e148-e163. doi: 10.1093/biostatistics/kxy063.
The goals in clinical and cohort studies often include evaluation of the association of a time-dependent binary treatment or exposure with a survival outcome. Recently, several impactful studies targeted the association between initiation of aspirin and survival following colorectal cancer (CRC) diagnosis. The value of this exposure is zero at baseline and may change its value to one at some time point. Estimating this association is complicated by having only intermittent measurements on aspirin-taking. Commonly used methods can lead to substantial bias. We present a class of calibration models for the distribution of the time of status change of the binary covariate. Estimates obtained from these models are then incorporated into the proportional hazard partial likelihood in a natural way. We develop non-parametric, semiparametric, and parametric calibration models, and derive asymptotic theory for the methods that we implement in the aspirin and CRC study. We further develop a risk-set calibration approach that is more useful in settings in which the association between the binary covariate and survival is strong.
在临床和队列研究中,目标通常包括评估时间相关的二分类治疗或暴露与生存结果之间的关联。最近,几项有影响力的研究针对阿司匹林的起始使用与结直肠癌(CRC)诊断后的生存之间的关联。这种暴露在基线时的价值为零,并且可能在某个时间点变为一。由于只能对服用阿司匹林进行间歇性测量,因此估计这种关联很复杂。常用的方法可能会导致严重的偏差。我们提出了一类用于二分类协变量状态变化时间分布的校准模型。然后,从这些模型中获得的估计值将以自然的方式纳入比例风险部分似然中。我们开发了非参数、半参数和参数校准模型,并为我们在阿司匹林和 CRC 研究中实施的方法推导了渐近理论。我们进一步开发了一种风险集校准方法,在二分类协变量与生存之间的关联较强的情况下,该方法更有用。